🎯 check Maraviroc (UK-427857) product page
Maraviroc (UK-427857) is a potent, allosteric CCR5 antagonist. It affects CCL5/CCR5 and PI3K/AKT signaling pathways by binding to the receptor's transmembrane domain and stabilizing its inactive conformation, effectively inhibiting HIV-1 entry, macrophage polarization, and inflammation.